Cargando…
CAS12e (CASX2) CLEAVAGE OF CCR5: IMPACT OF GUIDE RNA LENGTH AND PAM SEQUENCE ON CLEAVAGE ACTIVITY
CRISPR/Cas is under development as a therapeutic tool for the cleavage, excision, and/or modification of genes in eukaryotic cells. While much effort has focused on CRISPR/Cas from Streptococcus pyogenes (SpCas9) and Staphylococcus aureus (SaCas9), alternative CRISPR systems have been identified usi...
Autores principales: | Armstrong, David A., Hudson, Taylor R., Hodge, Christine A., Hampton, Thomas H., Howell, Alexandra L., Hayden, Matthew S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881857/ https://www.ncbi.nlm.nih.gov/pubmed/36711562 http://dx.doi.org/10.1101/2023.01.02.522476 |
Ejemplares similares
-
PlmCas12e (CasX2) cleavage of CCR5: impact of guide RNA spacer length and PAM sequence on cleavage activity
por: Armstrong, David A., et al.
Publicado: (2023) -
Efficient cleavage resolves PAM preferences of CRISPR-Cas in human cells
por: Tang, Lianchao, et al.
Publicado: (2019) -
PAM recognition by miniature CRISPR–Cas12f nucleases triggers programmable double-stranded DNA target cleavage
por: Karvelis, Tautvydas, et al.
Publicado: (2020) -
Leverage of nuclease-deficient CasX for preventing pathological angiogenesis
por: Han, Haote, et al.
Publicado: (2023) -
Position of Deltaproteobacteria Cas12e nuclease cleavage sites depends on spacer length of guide RNA
por: Selkova, Polina, et al.
Publicado: (2020)